ILF3-DT

Across TCGA pan-cancer cohorts, ILF3-DT RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated ILF3-DT data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher ILF3-DT RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated ILF3-DT expression acts as an unfavorable survival marker, although some lineages such as UCS and CESC show a favorable association.

UCS, CESC, and PAAD are the cancer types where ILF3-DT RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Quartile	II,III,IV	0.588	0.155	.001	98	view →
CESC	OS	Median	All	0.935	0.811	<.001	58	view →
PAAD	DFS	Quartile	All	0.501	0.162	.001	26	view →
KIRC	OS	Median	All	0.850	0.761	<.001	24	view →
HNSC	DFS	Median	IV	0.712	0.571	.004	22	view →
LGG	DFS	Quartile	All	0.896	0.755	<.001	22	view →
LUSC	OS	Tertile	All	0.833	0.701	.002	20	view →
ACC	DFS	Quartile	III,IV	0.525	0.143	.001	18	view →
KIRP	OS	Median	All	0.791	0.582	.006	17	view →
THCA	DFS	Quartile	All	0.963	0.793	.003	16	view →
LUAD	OS	Median	All	0.460	0.271	.002	16	view →
CHOL	OS	Quartile	All	0.948	0.529	.016	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

ILF3-DT–UCS (DFS)

Open the UCS breakdown →